Powers will present at the 2026 340B Grantees Spring Conference in Houston, TX, May 28–30, a leading 340B conference for Ryan White Clinics, Federally Qualified Health Centers (FQHCs), and FQHC Look-alikes to come together and share the latest on compliance updates with the latest 340B program regulations, strategies for maximizing the benefits of the 340B program, ways to use data to improve patient outcomes and satisfaction, and 340B advocacy.
See below a guide to what topics our attorneys will be presenting on:
Friday, May 29, 2026
1:00 pm-2:00 pm | Federal Legislative and Operational Landscape Update | Peggy Tighe, Principal
2:45 pm-4:00 pm | Current Issues Related to STD Grantees | Delaney Bounds Wilson, Associate
Saturday, May 30, 2026
11:00 am – 12:15 pm | Data Analytics: Analytics to the Rescue | Jason Reddish, Principal
1:30 pm – 2:30 pm | From Policy to Practice: Navigating 340B Medicaid Carve-Outs with Proven State Models | Greg Doggett, Counsel
3:00 pm – 4:15 pm | Patient Discounts | Jason Reddish, Principal
3:00 pm – 4:15 pm | Modern Day Advocacy | Peggy Tighe, Principal
3:00 pm – 4:15 pm | Optimizing 340B Injectable Processes: Billing, Revenue and Compliance | Joella Roland, Counsel
For the full 340B Grantee Spring Conference agenda, click here.
Powers Pyles Sutter & Verville (“Powers”) has represented safety net providers and pharmacies participating in the 340B drug pricing program since the program’s inception in 1992. With decades of experience, Powers Attorneys provide strategic counsel on 340B compliance, Medicaid and Medicare reimbursement, contract pharmacy arrangements, audits, and complex drug pricing issues, helping clients navigate evolving federal and state requirements. The Firm also advances client interests through advocacy, coalition building, and engagement with Congress and federal agencies. To learn more about Powers’ Drug Pricing and 340B Practice, visit us at www.powerslaw.com/practicearea/drug-pricing/.